Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: a phase 2 PEMBROSARC trial cohort
Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: a phase [...]
Médecine de précision et inégalités sociales d’accès aux essais précoces en cancérologie
Médecine de précision et inégalités sociales d’accès aux essais précoces [...]
Radiomics complements clinical, radiological, and technical features to assess local control of colorectal cancer lung metastases treated with radiofrequency ablation
Radiomics complements clinical, radiological, and technical features to assess local [...]
Diffusion-weighted MRI and PET/CT reproducibility in epithelial ovarian cancers during neoadjuvant chemotherapy
Diffusion-weighted MRI and PET/CT reproducibility in epithelial ovarian cancers during [...]
Implementing a Machine Learning Strategy to Predict Pathologic Response in Patients With Soft Tissue Sarcomas Treated With Neoadjuvant Chemotherapy
Implementing a Machine Learning Strategy to Predict Pathologic Response in [...]
Assessment of Repeatability, Reproducibility, and Performances of T2 Mapping-Based Radiomics Features: A Comparative Study
Assessment of Repeatability, Reproducibility, and Performances of T2 Mapping-Based Radiomics [...]
Assessment of Repeatability, Reproducibility, and Performances of T2 Mapping-Based Radiomics Features: A Comparative Study
Assessment of Repeatability, Reproducibility, and Performances of T2 Mapping-Based Radiomics [...]
Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression
Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in [...]
“TNM” at study entry in phase I trials
"TNM" at study entry in phase I trials Bulletin du [...]
Phase I study of daily and weekly regimens of the orally administered MDM2 antagonist idasanutlin in patients with advanced tumors
Phase I study of daily and weekly regimens of the [...]